Britain’s AstraZeneca on Monday rejected a sweetened and “final” offer from Pfizer , undermining the US drugmaker’s plan for a merger to create the world’s biggest pharmaceuticals group.
via Business feed http://ift.tt/1sKu3qV
Labels: Business, China, Hong Kong